Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Get Free Report) shares were down 8.5% on Friday following insider selling activity. The company traded as low as $6.98 and last traded at $6.98.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Inc. (NASDAQ:MNMD – Get Free Report) shares gapped down before the market opened on Thursday . The stock had previously closed at $7.32, but opened at $7.15. Mind Medicine (MindMed) shares last traded ...

The MIND diet was specifically designed to combat cognitive decline, said the study's lead author, Dr. Russell Sawyer, an ...

在其他近期新闻中，也被称为MindMed的Mind Medicine在其运营方面取得了重大进展。这家生物制药公司被选入Nasdaq生物技术指数，展示了其强劲的财务健康状况。MindMed用于治疗广泛性焦虑障碍的实验性治疗MM120 ODT已获得英国药品和保健品监管局的创新通行证，这是加速英国新药开发和获取的关键一步。

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)的首席医疗官Dan Karlin最近出售了公司6,643股普通股。该公司是一家市值5.02亿美元的生物科技公司，其股票在过去一年中上涨超过100%。根据 InvestingPro 的数据，分析师对MNMD保持看好态度，多项关键指标显示公司财务状况良好。这次出售是在2024年12月26日执行的，属于根据规则10b5- ...

International Mind-Body Wellness Day serves as an important reminder to prioritise both our mental and physical health.

Shares of Clearmind Medicine more than doubled after the Institutional Review Board approved a clinical trial of its flagship compound as a treatment for alcohol use disorder. The stock was changing ...

Clearmind Medicine Inc. Vancouver, Canada, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech ...

Scientists just discovered that a common cat parasite might be the key to treating brain disorders. Here's how this weird breakthrough could change ev ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...